What is Actuate Therapeutics, Inc. Common stock?
, a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 13.60M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.